Rachel Tomko to Adult
This is a "connection" page, showing publications Rachel Tomko has written about Adult.
Connection Strength
0.710
-
Distress tolerance and reactivity to negative affective cues in naturalistic environments of cannabis-using emerging adults. Drug Alcohol Depend. 2022 09 01; 238:109588.
Score: 0.060
-
Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers. Nicotine Tob Res. 2020 01 27; 22(1):81-88.
Score: 0.050
-
Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology (Berl). 2020 Feb; 237(2):479-490.
Score: 0.050
-
An electronic, smart lighter to measure cigarette smoking: A pilot study to assess feasibility and initial validity. Addict Behav. 2019 11; 98:106052.
Score: 0.049
-
Using REDCap for ambulatory assessment: Implementation in a clinical trial for smoking cessation to augment in-person data collection. Am J Drug Alcohol Abuse. 2019; 45(1):26-41.
Score: 0.044
-
Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend. 2018 01 01; 182:1-7.
Score: 0.043
-
Alcohol consumption as a predictor of reactivity to smoking and stress cues presented in the natural environment of smokers. Psychopharmacology (Berl). 2017 Feb; 234(3):427-435.
Score: 0.040
-
Undifferentiated negative affect and impulsivity in borderline personality and depressive disorders: A momentary perspective. J Abnorm Psychol. 2015 Aug; 124(3):740-753.
Score: 0.037
-
Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. J Pers Disord. 2014 Oct; 28(5):734-50.
Score: 0.035
-
Measuring impulsivity in daily life: the momentary impulsivity scale. Psychol Assess. 2014 Jun; 26(2):339-49.
Score: 0.033
-
Determining the impact of cannabis use and severity on tobacco cessation outcomes: study protocol for a prospective tobacco treatment trial. BMC Psychol. 2023 Jan 25; 11(1):25.
Score: 0.016
-
Characterization of Salivary Progesterone in Female Smokers. Nicotine Tob Res. 2022 10 26; 24(11):1829-1833.
Score: 0.015
-
Reporting Treatment Fidelity in Behavioral Tobacco Treatment Clinical Trials: Scoping Review and Measurement Recommendations. Nicotine Tob Res. 2022 02 01; 24(2):150-159.
Score: 0.015
-
A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth. Drug Alcohol Depend. 2022 03 01; 232:109311.
Score: 0.014
-
Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers. Drug Alcohol Depend. 2021 08 01; 225:108815.
Score: 0.014
-
Mobile, Remote, and Individual Focused: Comparing Breath Carbon Monoxide Readings and Abstinence Between Smartphone-Enabled and Stand-Alone Monitors. Nicotine Tob Res. 2021 03 19; 23(4):741-747.
Score: 0.014
-
Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults. Nicotine Tob Res. 2020 07 16; 22(8):1374-1382.
Score: 0.013
-
Examining sex, adverse childhood experiences, and oxytocin on neuroendocrine reactivity in smokers. Psychoneuroendocrinology. 2020 10; 120:104752.
Score: 0.013
-
Increases in endogenous progesterone attenuate smoking in a cohort of nontreatment seeking women: An exploratory prospective study. Addict Biol. 2021 03; 26(2):e12918.
Score: 0.013
-
The influence of gender and oxytocin on stress reactivity, cigarette craving, and smoking in a randomized, placebo-controlled laboratory relapse paradigm. Psychopharmacology (Berl). 2020 Feb; 237(2):543-555.
Score: 0.012
-
Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults. Drug Alcohol Depend. 2019 05 01; 198:105-111.
Score: 0.012
-
Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences. Exp Clin Psychopharmacol. 2019 Jun; 27(3):265-275.
Score: 0.012
-
Tobacco and cannabis co-use and interrelatedness among adults. Addict Behav. 2019 03; 90:354-361.
Score: 0.012
-
Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. Drug Alcohol Depend. 2018 11 01; 192:59-66.
Score: 0.011
-
Acceptability and compliance with a remote monitoring system to track smoking and abstinence among young smokers. Am J Drug Alcohol Abuse. 2018; 44(5):561-570.
Score: 0.011
-
The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial. Drug Alcohol Depend. 2018 04 01; 185:17-22.
Score: 0.011
-
Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. J Subst Abuse Treat. 2017 10; 81:53-58.
Score: 0.011
-
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257.
Score: 0.011
-
Countering Craving with Disgust Images: Examining Nicotine Withdrawn Smokers' Motivated Message Processing of Anti-Tobacco Public Service Announcements. J Health Commun. 2017 03; 22(3):254-261.
Score: 0.010
-
Does hangover influence the time to next drink? An investigation using ecological momentary assessment. Alcohol Clin Exp Res. 2014 May; 38(5):1461-9.
Score: 0.008
-
The influence of general identity disturbance on reports of lifetime substance use disorders and related outcomes among sexual minority adults with a history of substance use. Psychol Addict Behav. 2011 Sep; 25(3):530-41.
Score: 0.007
-
Distinguishing general and specific personality disorder features and implications for substance dependence comorbidity. J Abnorm Psychol. 2011 Aug; 120(3):656-69.
Score: 0.007
-
Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord. 2010 Aug; 24(4):412-26.
Score: 0.007